<DOC>
	<DOCNO>NCT01572324</DOCNO>
	<brief_summary>This Phase II clinical trial study effectiveness safety continuous hepatic arterial infusion ( HAI ) Oxaliplatin Fluorouracil Patients Unresectable Biliary tract carcinoma , explore well first-line treatment regimen patient .</brief_summary>
	<brief_title>Study Hepatic Arterial Infusion Treat Biliary Tract Carcinomas</brief_title>
	<detailed_description />
	<mesh_term>Biliary Tract Neoplasms</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<criteria>Patient must histologically cytologically confirm Biliary tract carcinoma include intrahepatic , hilar cholangiocarcinoma gallbladder cancer without evident liver metastasis . Patient must locally advanced disease unresectable review Hepatobiliary Surgery service Patient 's Eastern Cooperative Oncology Group ( ECOG ) performance status must = &lt; 2 ( Karnofsky &gt; = 60 % ) Absolute neutrophil count &gt; = 1,500/mcL Platelets &gt; = 100,000/mcL Hemoglobin &gt; = 90g/L Total bilirubin = &lt; 2 X institutional upper limit normal Aspartate aminotransferase ( AST ) ( serum glutamic oxaloacetic transaminase [ SGOT ] ) /alanine aminotransferase ( ALT ) ( serum glutamic pyruvate transaminase [ SGPT ] ) = &lt; 2.5 X institutional upper limit normality Creatinine = &lt; 1.5 X institutional upper limit normal Albumin &gt; = 30g/L Patient must able understand willing sign write informed consent document Patients prior chemotherapy antitumor therapy treatment Patient receive investigational agent Patient evident distant ( M ) disease ; Patient diagnosis hepatic encephalopathy Patients diagnosis sclerosing cholangitis . Patients diagnosis Gilbert 's disease . Patients clinical ascites Patient must uncontrolled concurrent illness include , limited , ongoing active infection , symptomatic congestive heart failure , unstable angina pectoris , cardiac arrhythmia , uncontrolled diabetes mellitus hypertension , psychiatric illness/social situation would limit compliance study requirement No malignancy except localize basal cell squamous cell skin cancer past 5 year Patient pregnant lactate Patient Allergic Iodine contrast medium Uncontrolled severe coagulation disorder ( INR &lt; 1.5 patient warfarin therapy )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Cholangiocarcinoma</keyword>
	<keyword>gallbladder cancer</keyword>
	<keyword>Infusions</keyword>
	<keyword>Intra-Arterial</keyword>
</DOC>